Medicine and Dentistry
Neoplasm
100%
Soft Tissue Sarcoma
69%
Metastatic Carcinoma
55%
Sarcoma
42%
Disease
37%
Liposarcoma
36%
Malignant Peripheral Nerve Sheath Tumor
34%
Surgery
28%
Desmoid Tumor
27%
Malignant Neoplasm
27%
Recurrent Disease
24%
In Vitro
22%
Protein P53
22%
Leiomyosarcoma
21%
Breast Cancer
20%
Tumor Necrosis Factor
20%
Dedifferentiated Liposarcoma
20%
Cancer
19%
Limb Perfusion
18%
Tumor Progression
18%
Tissue Microarray
17%
Tumor Cell
16%
Nodular Melanoma
16%
Programmed Cell Death
15%
Sarcoma Cell
15%
Angiosarcoma
14%
Retroperitoneal Sarcoma
14%
Overall Survival
13%
Limb
13%
Xenograft
13%
Vasculotropin
12%
Melphalan
12%
Gastrointestinal Stromal Tumor
12%
Well Differentiated Liposarcoma
12%
Epidermal Growth Factor Receptor
11%
Biological Marker
11%
Cell Line
10%
Catenin
10%
Diagnosis
10%
Interleukin 8
10%
Disease Specific Survival
9%
Doxorubicin
9%
Lung Metastasis
9%
Histone Deacetylase Inhibitor
9%
Immunohistochemistry
9%
Optical Coherence Tomography
9%
Epithelioid Sarcoma
9%
Mammalian Target of Rapamycin
8%
Melanoma Cell
8%
Liposarcoma Cell
8%
Keyphrases
Soft Tissue Sarcoma
76%
Tumor
63%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
34%
Dedifferentiated Liposarcoma (DDLPS)
34%
Desmoid Tumor
32%
Metastasis
29%
Sarcoma
23%
Liposarcoma
23%
Tumor Necrosis Factor-α
20%
Sarcoma Cells
19%
Isolated Limb Perfusion
17%
Myxoid Liposarcoma
16%
Retroperitoneal Sarcoma
16%
Tissue Microarray
16%
Putative Drug Targets
15%
Chemotherapy
15%
Local Recurrence
15%
Tumor Cells
15%
Catenin
15%
Leiomyosarcoma
14%
Apoptosis
14%
Retroperitoneal Liposarcoma
13%
Angiosarcoma
12%
Vascular Endothelial Growth Factor
12%
Tumor Growth
12%
Gastrointestinal Stromal Tumor
12%
Dedifferentiated
12%
Well-differentiated
12%
Melphalan
12%
Breast Cancer
11%
Malignancy
11%
Overall Survival
11%
Interleukin-8
11%
Disease-specific Survival
11%
Human Soft Tissue
10%
Prognosticator
10%
CTNNB1
10%
Platelet-derived Growth factor-BB (PDGF-BB)
10%
Mammalian Target of Rapamycin (mTOR)
10%
Platelet-derived Growth Factor Receptor (PDGFR)
10%
Optical Coherence Tomography
10%
Immunohistochemistry
10%
Desmoid
9%
Overexpression
9%
Epidermal Growth Factor Receptor
9%
Histone Deacetylase Inhibitor (HDACi)
9%
Epithelioid Sarcoma
9%
Tumor Metastasis
8%
Undifferentiated Pleomorphic Sarcoma
8%
Quantitative PCR
8%